Cargando…

A Comprehensive Visual Rating Scale for Predicting Progression from Mild Cognitive Impairment to Dementia in Patients with Alzheimer's Pathology or Suspected Non-Alzheimer's Pathology

BACKGROUND AND PURPOSE: To identify biomarkers for prediction of the progression to dementia in mild cognitive impairment (MCI) patients, evaluation of brain structure changes has been validated by a comprehensive visual grading scale (CVRS) through magnetic resonance imaging (MRI). In this study, w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Sang Won, Kim, Seongheon, Park, Jeonghoon, Jang, Jae-Won, Kim, SangYun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Dementia Association 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781734/ https://www.ncbi.nlm.nih.gov/pubmed/33377666 http://dx.doi.org/10.12779/dnd.2020.19.4.129

Ejemplares similares

A ‘Comprehensive Visual Rating Scale’ for predicting progression to dementia in patients with mild cognitive impairment
por: Jang, Jae-Won, et al.
Publicado: (2018)

Predicting progression to dementia with “comprehensive visual rating scale” and machine learning algorithms
por: Park, Chaeyoon, et al.
Publicado: (2022)

Immunity gene IFITM3 variant: Relation to cognition and Alzheimer's disease pathology
por: Pyun, Jung‐Min, et al.
Publicado: (2022)

Dynamic association between AT(N) profile and cognition mediated by cortical thickness in Alzheimer’s continuum
por: Jang, Jae-Won, et al.
Publicado: (2020)

miR-129-5p as a biomarker for pathology and cognitive decline in Alzheimer’s disease
por: Han, Sang-Won, et al.
Publicado: (2023)

The Validity and Reliability of the Mini-Mental State Examination-2 for Detecting Mild Cognitive Impairment and Alzheimer’s Disease in a Korean Population
por: Baek, Min Jae, et al.
Publicado: (2016)

Posterior atrophy predicts time to dementia in patients with amyloid-positive mild cognitive impairment
por: Pyun, Jung-Min, et al.
Publicado: (2017)

A case of possibly pathogenic PSEN2 R62C mutation in a patient with probable early-onset Alzheimer’s dementia supported by structure prediction
por: Park, Kyung Won, et al.
Publicado: (2017)

Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
por: Cicognola, Claudia, et al.
Publicado: (2021)

Microglial immunophenotype in dementia with Alzheimer’s pathology
por: Minett, Thais, et al.
Publicado: (2016)

Phosphodiesterase 5 inhibitor mirodenafil ameliorates Alzheimer-like pathology and symptoms by multimodal actions
por: Kang, Byung Woo, et al.
Publicado: (2022)

Differential White Matter Connectivity in Early Mild Cognitive Impairment According to CSF Biomarkers
por: Lim, Jae-Sung, et al.
Publicado: (2014)

Analysis of treatment pattern of anti-dementia medications in newly diagnosed Alzheimer’s dementia using OMOP CDM
por: Byun, JungHyun, et al.
Publicado: (2022)

Alpha-synuclein: a pathological factor with Aβ and tau and biomarker in Alzheimer’s disease
por: Shim, Kyu Hwan, et al.
Publicado: (2022)

Prevalence of Alzheimer’s Pathologic Endophenotypes in Asymptomatic and Mildly Impaired First-Degree Relatives
por: Lampert, Erika J., et al.
Publicado: (2013)

Mild behavioral impairment and its relation to tau pathology in preclinical Alzheimer’s disease
por: Johansson, Maurits, et al.
Publicado: (2021)

Efficacy and tolerability of rivastigmine patch therapy in patients with mild-to-moderate Alzheimer’s dementia associated with minimal and moderate ischemic white matter hyperintensities: A multicenter prospective open-label clinical trial
por: Park, Kyung Won, et al.
Publicado: (2017)

Telomere shortening reflecting physical aging is associated with cognitive decline and dementia conversion in mild cognitive impairment due to Alzheimer’s disease
por: Koh, Seong-Ho, et al.
Publicado: (2020)

Mutations in presenilin 2 and its implications in Alzheimer’s disease and other dementia-associated disorders
por: Cai, Yan, et al.
Publicado: (2015)

PET-validated EEG-machine learning algorithm predicts brain amyloid pathology in pre-dementia Alzheimer’s disease
por: Kim, Nam Heon, et al.
Publicado: (2023)

Cognitive Blackouts in Mild Cognitive Impairment and Alzheimer's Dementia
por: Adler, Georg, et al.
Publicado: (2018)

Pathological drivers of neurodegeneration in suspected non-Alzheimer’s disease pathophysiology
por: Wisse, L. E. M., et al.
Publicado: (2021)

Hydrocephalus in a Patient with Alzheimer's Disease
por: Kang, Min Ju, et al.
Publicado: (2018)

O-GlcNAcylation ameliorates the pathological manifestations of Alzheimer’s disease by inhibiting necroptosis
por: Park, Jinsu, et al.
Publicado: (2021)

Dementia with Lewy Bodies versus Alzheimer's Disease and Parkinson's Disease Dementia: A Comparison of Cognitive Profiles
por: Park, Kyung Won, et al.
Publicado: (2011)

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease
por: Jack, Clifford R., et al.
Publicado: (2009)

Gram-negative bacteria and their lipopolysaccharides in Alzheimer’s disease: pathologic roles and therapeutic implications
por: Kim, Hyeon soo, et al.
Publicado: (2021)

Comprehensive Visual Rating Scale on Magnetic Resonance Imaging: Application to Prodromal Alzheimer Disease
por: Chung, Jae Kyung, et al.
Publicado: (2021)

Novel PSEN1 G209A mutation in early-onset Alzheimer dementia supported by structural prediction
por: An, Seong Soo A., et al.
Publicado: (2016)

Predicting neurocognitive function with hippocampal volumes and DTI metrics in patients with Alzheimer's dementia and mild cognitive impairment
por: Shim, Geumsook, et al.
Publicado: (2017)

Prediction of conversion to dementia using interpretable machine learning in patients with amnestic mild cognitive impairment
por: Chun, Min Young, et al.
Publicado: (2022)

False Memory and Alzheimer's Disease Pathology in Patients with Amnestic Mild Cognitive Impairment: A Study with Amyloid PET
por: Choi, Eun-Ji, et al.
Publicado: (2021)

Quality Reporting of Radiomics Analysis in Mild Cognitive Impairment and Alzheimer's Disease: A Roadmap for Moving Forward
por: Won, So Yeon, et al.
Publicado: (2020)

On the Potential Benefit of Shunt Surgery in Idiopathic Normal-Pressure Hydrocephalus Patients with Alzheimer's Disease Pathology
por: Kang, Kyunghun, et al.
Publicado: (2021)

Predictability of polygenic risk score for progression to dementia and its interaction with APOE ε4 in mild cognitive impairment
por: Pyun, Jung-Min, et al.
Publicado: (2021)

Association between Visceral Adipose Tissue Metabolism and Alzheimer’s Disease Pathology
por: Kim, Shin, et al.
Publicado: (2022)

Visuospatial memory impairment as a potential neurocognitive marker to predict tau pathology in Alzheimer’s continuum
por: Seo, Eun Hyun, et al.
Publicado: (2021)

Predictive Scale for Amyloid PET Positivity Based on Clinical and MRI Variables in Patients with Amnestic Mild Cognitive Impairment
por: Chun, Min Young, et al.
Publicado: (2022)

Impaired comprehension of metaphorical expressions in very mild Alzheimer’s disease
por: Fujimoto, Norimasa, et al.
Publicado: (2019)

Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia
por: Chiu, Pai-Yi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jovg99hf8hfqhb2oja396o23r0